1: Park MH, Lee YY, Cho KH, La S, Lee HJ, Yim DS, Ban S, Park MY, Kim YC, Kim YG, Shin YG. Validation of a liquid chromatography-triple quadrupole mass spectrometric method for the determination of 5-Nitro-5'-Hydroxy-Indirubin-3'-Oxime (AGM-130) in human plasma and its application to microdose clinical trial. Biomed Chromatogr. 2015 Jul 2. doi: 10.1002/bmc.3551. [Epub ahead of print] doi: 10.1155/2015/484670. Epub 2015 May 18. 3: Yan L, Lai F, Chen X, Xiao Z. Discovery of novel indirubin-3'-monoxime derivatives as potent inhibitors against CDK2 and CDK9. Bioorg Med Chem Lett. 2015 Jun 1;25(11):2447-51. doi: 10.1016/j.bmcl.2015.03.066. Epub 2015 Mar 31. doi: 10.1517/13543776.2015.1019865. doi: 10.1007/s10529-015-1824-2. Epub 2015 Apr 8. Epub 2015 Feb 9. 7: Song JH, Lee JE, Cho KM, Park SH, Kim HJ, Kim YC, Kim TS. 5-diphenylacetamido-indirubin-3'-oxime as a novel mitochondria-targeting agent with anti-leukemic activities. Mol Carcinog. 2015 Mar 18. doi: 10.1002/mc.22307. [Epub ahead of print] doi: 10.1016/j.bmcl.2015.02.053. Epub 2015 Feb 28. doi: 10.4149/neo_2015_026. doi: 10.1016/j.vph.2014.10.005. Epub 2014 Nov 5. doi: 10.1002/ardp.201400223. Epub 2014 Sep 2. doi: 10.1016/j.bbrc.2014.09.034. Epub 2014 Sep 16. doi: 10.1016/j.bcp.2014.07.009. Epub 2014 Jul 25. doi: 10.1016/j.ejphar.2014.07.035. Epub 2014 Jul 24. doi: 10.3892/ijo.2014.2548. Epub 2014 Jul 21. doi: 10.1111/jphp.12286. Epub 2014 Jun 24. doi: 10.1186/1756-3305-7-234.